Page 72 - Read Online

Zavridis et al. Radio frequency neurolysis for pain reduction

twice the threshold value of the sensory test. Sensory tream/10665/37896/1/9241544821.pdf.
testing increases the technique’s efficacy, and motor 5. Vayne-Bossert P, Afsharimani B, Good P, Gray P, Hardy J.
stimulation ensures safety from motor impairment. Interventional options for the management of refractory cancer pain--
what is the evidence? Support Care Cancer 2016;24:1429-38.
6. Martin BC, Fan MY, Edlund MJ, Devries A, Braden JB, Sullivan
Limitations of our study include its retrospective nature MD. Long-term chronic opioid therapy discontinuation rates from the
as well as the diversity of the malignant substrate. TROUP study. J Gen Intern Med 2011;26:1450-7.
Additionally, there was no randomized comparison 7. Ballantyne JC, Kalso E, Stannard C. WHO analgesic ladder: a good
between continuous RF neurolysis and placebo concept gone astray. BMJ 2016;352:i20.
therapy, chemical neurolysis with phenol or alcohol, or 8. Vallejo R, Benjamin RM, Aliaga L. Radiofrequency vs. pulse
radiofrequency: the end of the controversy. Tech Region Anesth Pain
medical management. Manage 2010;14:128-32.
9. de Louw AJ, Vles HS, Freling G, Herpers MJ, Arends JW, Kleef M.
Radiofrequency neurolysis under CT guidance is The morphological effects of a radio frequency lesion adjacent to the
feasible and reproducible, efficient (70-80% success dorsal root ganglion (RF-DRG) -- an experimental study in the goat.
rate), and safe (> 0.5% mean complications rate) as Eur J Pain 2001;5:169-74.
palliative therapy for pain reduction in oncologic patients 10. Kvarstein G. Pulsed radiofrequency -- time for a clinical pause and
more science. Scand J Pain 2012;3:124-6.
with refractory pain. Thorough knowledge of nervous 11. Cahara A, van Zundert J, Macrea L, van Kleef M, Sluijter M. Pulsed
system anatomy and pain transmission pathways is radiofrequency: current clinical and biological literature available.
essential for proper patient and technique selection. Pain Med 2006;7:411-23.
12. Malik K, Benzon HT, Walega D. Water-cooled radiofrequency:
Authors’ contributions a neuroablative or a neuromodulatory modality with broader
Text writing: P. Zavridis, A. Mazioti applications? Case Rep Anesthesiol 2011;2011:263101.
Statistic analysis: M. Tsitskari 13. Locklin JK, Mannes A, Berger A, Wood BJ. Palliation of soft
Submission editing: D. Filippiadis tissue cancer pain with radiofrequency ablation. J Support Oncol
2004;2:439-45.
14. Bhaskar AK. Interventional management of cancer pain. Curr Opin
Financial support and sponsorship Support Palliat Care 2012;6:1-9.
None. 15. de Courcy JG. Interventional techniques for cancer pain management.
Clin Oncol (R Coll Radiol) 2011;23:407-17.
Conflicts of interest 16. Uchida K. Radiofrequency treatment of the thoracic paravertebral
There are no conflicts of interests. nerve combined with glucocorticoid for refractory neuropathic pain
following breast cancer surgery. Pain Physician 2009;12:E277-83.
Patient consent 17. Papadopoulos D, Kostopanagiotou G, Batistaki C. Bilateral
thoracic splanchnic nerve radiofrequency thermocoagulation for the
Patient consent was obtained. management of end-stage pancreatic abdominal cancer pain. Pain
Physician 2013;16:125-33.
Ethics approval 18. Vissers KC, Besse K, Wagemans M, Zuurmond W, Giezeman MJ,
Ethics approval was obtained. Lataster A, Mekhail N, Burton AW, van Kleef M, Huygen F. 23. Pain
in patients with cancer. Pain Pract 2011;11:453-75.
REFERENCES 19. Zhong W, Yu Z, Zeng JX, Lin Y, Yu T, Min XH, Yuan YH, Chen QK.
Celiac plexus block for treatment of pain associated with pancreatic
cancer: a meta-analysis. Pain Pract 2014;14:43-51.
1. Prommer EE. Pharmacological management of cancer-related pain. 20. Plancarte R, de Leon-Casasola OA, El-Helaly M, Allende S, Lema
Cancer Control 2015;22:412-25. MJ. Neurolytic superior hypogastric plexus block for chronic pelvic
2. Coleman R, Body JJ, Aapro M, Hadji P, Herrstedt J; ESMO Guidelines pain associated with cancer. Reg Anesth 1997;22:562-8.
Working Group. Bone health in cancer patients: ESMO Clinical 21. Arcidiacono PG, Calori G, Carrara S, McNicol ED, Testoni PA. Celiac
Practice Guidelines. Ann Oncol 2014;25 Suppl 3:iii124-37. plexus block for pancreatic cancer pain in adults. Cochrane Database
3. Ripamonti CI, Santini D, Maranzano E, Berti M, Roila F; ESMO Syst Rev 2011;(3):CD007519.
Guidelines Working Group. Management of cancer pain: ESMO 22. Puli SR, Reddy JB, Bechtold ML, Antillon MR, Brugge WR. EUS-
Clinical Practice Guidelines. Ann Oncol 2012;23 Suppl 7:vii139-54. guided celiac plexus neurolysis for pain due to chronic pancreatitis
4. World Health Organization. Cancer pain relief: with a guide to opioid or pancreatic cancer pain: a meta-analysis and systematic review. Dig
availability. 2nd ed. 1996. Available from: http://apps.who.int/iris/bits Dis Sci 2009;54:2330-7.

64 Journal of Cancer Metastasis and Treatment ¦ Volume 3 ¦ March 27, 2017